Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Aso, Saeed"'
Autor:
Sigridur Elíasdóttir, Alina Khramova, Aso Saeed, Gregor Guron, Roberto Boi, Johan Mölne, Kerstin Ebefors, Jenny Nyström
Publikováno v:
BMC Nephrology, Vol 24, Iss 1, Pp 1-10 (2023)
Abstract Introduction IgA nephropathy (IgAN) is the most common glomerulonephritis globally. Because of the heterogeneity of the disease prognostic biomarkers are highly needed. Aim To investigate associations between galactose-deficient IgA1 (Gd-IgA
Externí odkaz:
https://doaj.org/article/fa999b1326ad4d80a138e2015caabf9e
Autor:
Pavlos Kashioulis, Cecilia Wallentin Guron, Maria K. Svensson, Ola Hammarsten, Aso Saeed, Gregor Guron
Publikováno v:
ESC Heart Failure, Vol 7, Iss 5, Pp 2797-2806 (2020)
Abstract Aims The overall aim was to identify sub‐clinical cardiac abnormalities by echocardiography in patients with chronic kidney disease (CKD) stages 3 and 4 and to investigate underlying mechanisms. Methods and results Ninety‐one patients wi
Externí odkaz:
https://doaj.org/article/115b6ee4e958473d917b28562eca6aa7
Autor:
Hanna Jansson, Aso Saeed, Maria K. Svensson, Kristina Finnved, Mikael Hellström, Gregor Guron
Publikováno v:
Kidney & Blood Pressure Research, Pp 1-11 (2019)
Background/Aim: Calcifications of large arteries are frequent in chronic kidney disease (CKD) and may contribute to the high cardiovascular risk in this population. The aim of this study was to examine whether abdominal aortic calcification volume (A
Externí odkaz:
https://doaj.org/article/a369d669ef0b429fb8ac8467d59e7b90
Autor:
Pavlos Kashioulis, Jaana Lundgren, Emman Shubbar, Lisa Nguy, Aso Saeed, Cecilia Wallentin Guron, Gregor Guron
Publikováno v:
Kidney & Blood Pressure Research, Vol 43, Iss 4, Pp 1053-1064 (2018)
Background/Aims: Cardiovascular disease is the major cause of death in patients with chronic kidney disease (CKD). Rats with adenine-induced chronic renal failure (ACRF) develop severe renal insufficiency and metabolic abnormalities that closely rese
Externí odkaz:
https://doaj.org/article/9552632cc44540e58b4fa86ee817f8b4
Autor:
Arndís Finna Ólafsdóttir, Mervi Andelin, Aso Saeed, Sheyda Sofizadeh, Hussein Hamoodi, Per-Anders Jansson, Marcus Lind
Publikováno v:
World Journal of Clinical Cases. 10:7794-7807
Autor:
Jan, Melin, Aso, Saeed
Publikováno v:
Lakartidningen. 119
The recently published Kidney Disease Improving Global Outcomes (KDIGO) guideline on blood pressure (BP) management in chronic kidney disease (CKD) recommends a target systolic BP of120 mm Hg in all adults with hypertension and CKD. This recommendati
Brain Natriuretic Peptides in Atherosclerotic Renal Artery Stenosis and Effects of Renal Angioplasty
Autor:
Elzbieta Nowakowska-Fortuna, Aso Saeed, Gregor Guron, Michael Fu, Ola Hammarsten, Gert Jensen, Hans Herlitz
Publikováno v:
Kidney & Blood Pressure Research, Vol 37, Iss 6, Pp 657-666 (2013)
Background: We hypothesized that plasma levels of brain natriuretic peptide (BNP) and N-terminal pro-BNP (NT-proBNP) would be elevated, and adiponectin concentrations reduced, in patients with atherosclerotic renal artery stenosis (ARAS) and that BNP
Externí odkaz:
https://doaj.org/article/d075cfebea9f419aa0b7985ce291d20b
Publikováno v:
International Journal of Environmental Studies
In the absence of a definitive global therapy for coronavirus, COVID-19, disease, the Health Ministry of Kurdistan Region of Iraq decided to use convalescent plasma for coronavirus patients. The de...
Autor:
Marcus Lind, Aso Saeed, Sofia Dahlqvist, Johan Mårtensson, Henrik Imberg, Sheyda Sofizadeh, Mary Dena, Irl B. Hirsch, Jaakko Tuomilehto, Magnus Wijkman, Ole Torffvit
Publikováno v:
J Clin Hypertens (Greenwich)
Liraglutide is associated with blood pressure reduction in patients with type 2 diabetes. However, it is not known whether this blood pressure reduction can be predicted prior to treatment initiation, and to what extent it correlates with weight loss
Autor:
Gregor Guron, Cecilia Wallentin Guron, Pavlos Kashioulis, Ola Hammarsten, Maria Svensson, Aso Saeed
Publikováno v:
ESC Heart Failure, Vol 7, Iss 5, Pp 2797-2806 (2020)
AIMS: The overall aim was to identify sub-clinical cardiac abnormalities by echocardiography in patients with chronic kidney disease (CKD) stages 3 and 4 and to investigate underlying mechanisms. METHODS AND RESULTS: Ninety-one patients with CKD stag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74f045fb5338f8bf3f0176288c3f46e3
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-431982
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-431982